Pleiotrophic actions of erythropoietin.

Environ Health Prev Med

Laboratory for Cell and Molecular Biology, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, 330 Brookline Ave., W/BL 548, 02215, Boston, Massachusetts, USA.

Published: January 2003

Erythropoietin is the prime regulator of red blood cell production. However, recent evidence suggests that the hormone has multiple effects outside the hematopoietic system. Functional receptors have been identified on a wide variety of normal and malignant cell types, and numerous biologic effects of the hormone on these cells have been observed both in vitro and in vivo. These findings are causing a reassessment of the understanding of erythropoietin physiology. Moreover, there are important implications for the use of recombinant erythropoietin in the clinical setting.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723462PMC
http://dx.doi.org/10.1007/BF02908882DOI Listing

Publication Analysis

Top Keywords

pleiotrophic actions
4
erythropoietin
4
actions erythropoietin
4
erythropoietin erythropoietin
4
erythropoietin prime
4
prime regulator
4
regulator red
4
red blood
4
blood cell
4
cell production
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!